|Date: October 2012|
Third quarter of 2012:
Bayer on track for a successful 2012
Upward trend at HealthCare and CropScience continues / Sales advanced by 11.5 percent to EUR 9,665 million / EBIT of EUR 838 million (minus 23.7 percent) / EBITDA before special items improved by 2.2 percent to EUR 1,845 million / Net income of EUR 528 million (minus 17.8 percent) / Further progress with innovation pipeline / Group forecast for 2012 confirmed
Image size: 18 cm x 13 cm
Image author: Bayer AG
Image utilization: Photo may be used to accompany reports on Bayer provided the source is mentioned. Resale to third parties is prohibited.
Image size in KB: